Author

Erika L. Flannery

University of California San DiegoORCID 0000-0003-0665-7954Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Assay:whole-genome sequencing· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Elizabeth A. WinzeleriD· 2 shared Aaron R. JexiD· 1 shared Amanda K. LukensiD· 1 shared Amit Mahindra· 1 shared Ana Sanchez-Azqueta· 1 shared Andrew B. TobiniD· 1 shared Andrew G. JamiesoniD· 1 shared Andrew P. Waters· 1 shared

Activity by Year

2017-2018 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Elizabeth A. WinzelerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintDec 3, 2018

Transcriptome and histone epigenome of Plasmodium vivax salivary-gland sporozoites point to tight regulatory control and potential mechanisms for liver-stage differentiation.

Vivax Sporozoite Consortium, Ivo Muller, Aaron R. Jex…·Vorada Chuenchob

This study characterizes the transcriptome and histone epigenome of Plasmodium vivax sporozoites, revealing transcriptional and post-transcriptional control mechanisms and potential pathways for hypnozoite formation.

DOI 10.1101/145250

plant (other)bulk RNA-seq

𝕏 PostBluesky

MicrobiologybioRxivPreprintAug 31, 2018

Validation of the protein kinase PfCLK3 as a multi-stage cross species malarial drug target

Mahmood M Alam, Ana Sanchez-Azqueta, Omar Janha…·Andrew B. Tobin

This study identifies PfCLK3 as a druggable target for malaria by showing its essential role in multiple parasite life stages across species.

DOI 10.1101/404459

whole-genome sequencingproteomics

𝕏 PostBluesky

GenomicsbioRxivPreprintMay 22, 2017

Mapping The Malaria Parasite Drug-Able Genome Using In Vitro Evolution And Chemogenomics

Annie N. Cowell, Eva S. Istvan, Amanda K. Lukens…·Elizabeth A. Winzeler

Whole genome sequencing reveals how Plasmodium falciparum evolves resistance to diverse compounds and identifies new antimalarial drug targets.

1 citation

humanwhole-genome sequencing

𝕏 PostBluesky